INTELLISPHERE

Serial Number 87929600
Registration 6653955
700

Registration Progress

Application Filed
May 21, 2018
Under Examination
Dec 18, 2018
Approved for Publication
Oct 23, 2018
Published for Opposition
Oct 23, 2018
Registered
Feb 22, 2022

Trademark Image

INTELLISPHERE

Basic Information

Serial Number
87929600
Registration Number
6653955
Filing Date
May 21, 2018
Registration Date
February 22, 2022
Published for Opposition
October 23, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 22, 2022
Registration
Registered
Classes
005

Rights Holder

Contract Pharmacal Corp.

03
Address
135 Adams Ave.
Hauppauge, NY 11788

Ownership History

Contract Pharmacal Corp.

Original Applicant
03
Hauppauge, NY

Contract Pharmacal Corp.

Owner at Publication
03
Hauppauge, NY

Contract Pharmacal Corp.

Original Registrant
03
Hauppauge, NY

Legal Representation

Attorney
Dana S. Gross

USPTO Deadlines

Next Deadline
768 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20220222)
Due Date
February 22, 2028
Grace Period Ends
August 22, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Feb 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 15, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 14, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 16, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 9, 2021 IUAF S USE AMENDMENT FILED Loading...
Dec 9, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 15, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 8, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 15, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 8, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 26, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 17, 2020 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 17, 2020 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 26, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 26, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
May 26, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 16, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 5, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 5, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 5, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 18, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 23, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 23, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 3, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 12, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
May 29, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 24, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Drug delivery agents in the form of powders, liquids, creams, gels, and pastes that facilitate the delivery of therapeutic agents and pharmaceutical preparations; Drug delivery agents in the form of powders, liquids, creams, gels, and pastes that provide controlled release of the active ingredients for a wide variety of therapeutics and pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of therapeutics and pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based powders, liquids, creams, gels, and/or pastes for the continuous release of a wide variety of therapeutic and pharmaceutical agents
First Use Anywhere: Sep 13, 2021
First Use in Commerce: Sep 13, 2021

Classification

International Classes
005